Latest News

04/15/2014 - 12:02pm

Total spending on U.S. medicines increased 1% on a real per capita basis in 2013, while the use of healthcare services overall rose for the first time in three years, according to a new report issued today by the IMS Institute for Healthcare Informatics.

04/15/2014 - 11:45am

The Food and Drug Administration on Tuesday announced that it approved Tanzeum (albiglutide) subcutaneous injection, which is used to improve glycemic control in adults with Type 2 diabetes.

04/15/2014 - 11:23am

To kick-off the ninth annual Women of Worth program, L'Oréal Paris will convene thousands of women — including Maria Shriver, Arianna Huffington, Mika Brzezinski and L'Oreal Paris ambassadors Lea Michele, Eva Longoria and Liya Kebede — for the first-ever Women of Worth Twitter Forum on Wednesday.

04/15/2014 - 11:19am

Merck announced that the Food and Drug Administration has approved Grastek (Timothy grass pollen allergen extract) tablet for sublingual use.

04/15/2014 - 11:18am

Quest Products on Friday announced the addition of a gel formulated for emergency burn relief, Alocane Emergency Burn Gel, to its current line of products.

04/15/2014 - 11:13am

Safeway on Monday completed the distribution to its stockholders of 37.8 million shares of Class B common stock of Blackhawk Networks Holdings owned by Safeway.

04/15/2014 - 11:11am

Unilever’s Caress brand has named Adriana Castro, designer, style trendsetter and founder of El Diario de la Moda, as its new Caress Fabulistas to help celebrate the launch of the new Caress Fresh Body Wash collection.

04/15/2014 - 11:02am

Procter & Gamble’s Gillette brand is enhancing its collaboration with McLaren Mercedes to bring to life a marketing campaign focused on Precision Engineering.

04/15/2014 - 11:00am

Actavis on Tuesday announced that it has entered into an agreement with Mylan and Famy Care to settle all outstanding patent litigation related to Mylan's generic version of Generess FE (norethindrone, ethinyl estradiol and ferrous fumarate chewable tablets).

04/15/2014 - 10:49am

Prosonix, a speciality pharmaceutical company developing a portfolio of inhaled respiratory medicines by Design, on Tuesday announced that it has entered into a global licensing agreement with Mylan for its leading inhaled respiratory products, PSX1001 and PSX1050.